Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications
- 1 July 2007
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Hematology
- Vol. 14 (4), 348-353
- https://doi.org/10.1097/moh.0b013e328186ffbf
Abstract
Angioimmunoblastic T cell lymphoma is a complex lymphoproliferative disorder. While recent evidence suggests that the Epstein-Barr virus and B cell disregulation are implicated in the disease's pathogenesis, their mechanistic roles remain largely unknown. The prognosis with traditional chemotherapy has been poor, but improved understanding of the disease's pathobiology has led to several promising novel therapeutic strategies.The recent finding of overexpression of the chemokine CXCL13 by the neoplastic cells of angioimmunoblastic T cell lymphoma suggests that it is derived from follicular helper T cells. In addition, gene-expression profiling has demonstrated overexpression of several genes characteristic of follicular helper T cells. Vascular endothelial growth factor-A is also highly expressed. Novel therapeutic strategies including immunomodulation with agents like cyclosporine and angiogenesis inhibition with drugs such as bevacizumab are being investigated, and show early promise in this disease.Diseases such as angioimmunoblastic T cell lymphoma can help illuminate the biology of the normal immune system. Significant progress has been made in understanding the biology of angioimmunoblastic T cell lymphoma. This has paved the way for the development of new therapeutic strategies and these have shown interesting results.Keywords
This publication has 32 references indexed in Scilit:
- Expression of CXCL13 by Neoplastic Cells in Angioimmunoblastic T-Cell Lymphoma (AITL)The American Journal of Surgical Pathology, 2006
- Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecifiedLaboratory Investigation, 2006
- CXCL13 is an arrest chemokine for B cells in high endothelial venulesBlood, 2005
- Unique gene expression program of human germinal center T helper cellsBlood, 2004
- Epstein-Barr Virus–Associated B-Cell Lymphoproliferative Disorders in Angioimmunoblastic T-Cell Lymphoma and Peripheral T-Cell Lymphoma, UnspecifiedAmerican Journal of Clinical Pathology, 2002
- Peripheral T-Cell Lymphoma With Reed-Sternberg-like Cells of B-Cell Phenotype and Genotype Associated With Epstein-Barr Virus InfectionThe American Journal of Surgical Pathology, 1999
- Angioimmunoblastic-Like T-Cell Non Hodgkin's Lymphoma: Outcome After Chemotherapy in 33 Patients and Review of the LiteratureLeukemia & Lymphoma, 1999
- Angioimmunoblastic Lymphoma (AILD-Type T-cell Lymphoma) With Hyperplastic Germinal CentersThe American Journal of Surgical Pathology, 1998
- Angio-immunoblastic lymphadenopathyThe American Journal of Medicine, 1975
- ANGIO-IMMUNOBLASTIC LYMPHADENOPATHY WITH DYSPROTEINÆMIAThe Lancet, 1974